Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of DHA-PQ vs AL for Uncomplicated P. falciparum Malaria in Indonesia
NCT02325180Phase 4Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jan 2015
- Primary completion
- Jun 2015
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dihydroartemisinin + piperaquine in Plasmodium falciparum malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine at 42 days. Started Jan 2015; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02325180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02325180.